ABO Blood groups and genetic risk factors for thrombosis in croatian population

Croatian Medical Journal

Volumn 50, Issue 6, 2009, Pages 550-558

  Jukić, Irena ^a   Bingulac Popovicć, Jasna ^a   Dogić, Vesna ^a   Babić, Ivana ^a   Culej, Jelena ^b   Tomičić, Maja ^a   Vuk, Tomislav ^a   Šarlija, Dorotea ^a   Balija, Melita ^a  

^a CROATIAN INSTITUTE OF TRANSFUSION MEDICINE   (Croatia)

^b Ministarstva Zdravstva i Socijalne Skrbi RH   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; AGED; ARTICLE; BLOOD GROUP ABO SYSTEM; CONTROLLED STUDY; CROATIA; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; SEQUENCE ANALYSIS; THROMBOSIS;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CONFIDENCE INTERVALS; CROATIA; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREVALENCE; PROTHROMBIN; RISK FACTORS; THROMBOSIS; YOUNG ADULT;

EID: 75649116456     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2009.50.550     Document Type: Article

References (23)

1. Yamamoto F. Molecular genetics of the ABO histo-blood group system. Vox Sang. 1995;69:1. Medline:7483485 doi:10.1111/j.1423- 0410.1995.tb00339.x.
2. Garratty G. Relationship of blood groups to disease: do blood group antigens have a biological role? Rev Med Inst Mex Seguro Soc. 2005;43 Suppl 1:113-21.
3. Jick H, Slone D, Westerholm B, Inman WH, Vessey MP, Shapiro S, et al. Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet. 1969;1:539-42. Medline:4179835 doi:10.1016/S0140-6736(69)91955-2.
4. Amirzadegan A, Salarifar M, Sadeghian S, Davoodi G, Darabian C, Goodarzynejad H. Correlation between ABO blood groups, major risk factors, and coronary artery disease. Int J Cardiol. 2006;110:256-8. Medline:16087259 doi:10.1016/j.ijcard.2005.06.058. (Pubitemid 43767102)
5. Cesena FH, da Luz PL. ABO blood group and precocity of coronary artery disease. Thromb Res. 2006;117:401-2. Medline:15893808 doi:10.1016/j.thromres. 2005.03.023. (Pubitemid 43197491)
6. Larsen TB, Johnsen SP, Gislum M, Mřller CA, Larsen H, Sřrensen HT. ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested casecontrol study. J Thromb Haemost. 2005;3:300-4. Medline:15670036 doi:10.1111/j.1538-7836.2005. 01195.x. (Pubitemid 41623618)
7. Nydegger UE, Wuillemin WA, Julmy F, Meyer BJ, Carrel TP. Association of ABO histo-blood group B allele with myocardial infarction. Eur J Immunogenet. 2003;30:201-6. Medline:12786998 doi:10.1046/j.1365-2370.2003.00390.x. (Pubitemid 36724004)
8. Wu O, Bayoumi N, Vickers MA, Clark P. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost. 2008;6:62-9. Medline:17973651.
9. Bezemer ID, Rosendaal FR. Predictive genetic variants for venous thrombosis: what's new? Semin Hematol. 2007;44:85-92. Medline:17433900 doi:10.1053/j.seminhematol.2007.01.007. (Pubitemid 46551196)
10. Jenkins PV, O'Donnell JS. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? Transfusion. 2006;46:1836-44. Medline:17002642 doi:10.1111/j.1537- 2995.2006.00975.x.
11. Almawi WY, Tamim H, Kreidy R, Timson G, Rahal E, Nabulsi M, et al. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis. J Thromb Thrombolysis. 2005;19:189-96. Medline:16082606 doi:10.1007/s11239-005- 1313-x. (Pubitemid 41149481)
12. Hessner MJ, Dinauer DM, Luhm RA, Endres JL, Montgomery RR, Friedman KD. Contribution of the glycoprotein Ia 807TT, methylene tetrahydrofolate reductase 677TT and prothrombin 20210GA genotypes to prothrombotic risk among factor V 1691GA (Leiden) carriers. Br J Haematol. 1999;106:237-9. Medline:10444193 doi:10.1046/j.1365-2141.1999.01514.x. (Pubitemid 29343557)
13. Cattaneo M, Tsai MY, Bucciarelli P, Taioli E, Zighetti ML, Bignell M, et al. A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:Q506). Arterioscler Thromb Vasc Biol. 1997;17:1662-6. Medline:9327760.
14. Tosetto A, Missiaglia E, Frezzato M, Rodeghiero F. The VITA project: C677T mutation in the methylene-tetrahydrofolate reductase gene and risk of venous thromboembolism. Br J Haematol. 1997;97:804-6. Medline:9217179 doi:10.1046/j.1365-2141.1997.1422957.x.
15. Gassner C, Schmarda A, Nussbaumer W, Schönitzer D. ABO glycosyltransferase genotyping by polymerase chain reaction using sequence-specific primers. Blood. 1996;88:1852-6. Medline:8781444.
16. Tripodi A, Negri B, Bertina RM, Mannusi PM. Screening for the FV: Q506 mutation: evaluation of thirteen plasma-based methods for their diagnostic efficacy in comparison with DNA analysis. Thromb Haemost. 1997;77:436-9. Medline:9065989.
17. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-703. Medline:8916933.
18. Frosst P, Blom HJ, Milos R, Goyette P, SHeppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111-3. Medline:7647779 doi:10.1038/ng0595-111.
19. Morelli VM, De Visser MC, Vos HL, Bertina RM, Rosendaal FR. ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden. J Thromb Haemost. 2005;3:183-5. Medline:15634288 doi:10.1111/j.1538-7836.2004. 01071.x. (Pubitemid 41647137)
20. Procare-GEHT Group. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation. Br J Haematol. 2006;135:697-702. Medline:17107352 doi:10.1111/j.1365-2141.2006.06353.x. (Pubitemid 44674082)
21. Ohira T, Cushman M, Tsai MY, Zhang Y, Heckbert SR, Zakai NA, et al. ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost. 2007;5:1455-61. Medline:17425663 doi:10.1111/j.1538- 7836.2007.02579.x.
22. Gonzalez Ordonez AJ, Medina Rodriguez JM, Martin L, Alvarez V, Coto E. The O blood group protects against venous thromboembolism in individuals with the factor V Leiden but not the prothrombin (factor II G20210A) mutation. Blood Coagul Fibrinolysis. 1999;10:303-7. Medline:10456623 doi:10.1097/00001721- 199907000-00013.
23. Minano A, Ordonez A, Espana F, Gonzalez-Porras JR, Lecumberri R, Fontcuberta J, et al. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms. Haematologica. 2008;93:729-34. Medline:18387978 doi:10.3324/haematol.12271. (Pubitemid 351669313)